Cancer Invest 2022 Jun 22:1-39. Epub 2022 Jun 22.
DDS, PhD, Division of Oral Pathology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil and Professor, Department of Dentistry, Unichristus, Fortaleza, Ceará, Brazil.
We investigated the differences in prognosis according to the type of healthcare coverage of patients with oral and oropharyngeal squamous cell carcinoma (OOSCC). This study included 875 medical records. Patients covered by the publicly funded Unified Health System (SUS) had a low educational level, with advanced T-stage and delayed treatment initiation. Read More